Transitioning from tenofovir disoproxil fumarate (TDF) to besifovir dipivoxil maleate (BSV) in patients with chronic hepatitis B (CHB) (IMAGE)

Korea University College of Medicine

Transitioning from tenofovir disoproxil fumarate (TDF) to besifovir dipivoxil maleate (BSV) in patients with chronic hepatitis B (CHB)

Caption

A new study finds that switching from long-term TDF to BSV may improve renal and bone safety, with no differences observed in the antiviral efficacy.

Credit

Dr. Hyung Joon Yim from Korea University Ansan hospital

Usage Restrictions

Cannot be used without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.